Urine chemokines: Biomarkers of human lupus nephritis?

European Review for Medical and Pharmacological Sciences

Volumn 11, Issue 3, 2007, Pages 171-178

  Ferri, G M ^a   Gigante, Antonietta ^a   Ferri, F ^a   Amoroso, D ^a   Zardi, E ^b   Papa, A ^a   De Galasso, L ^b   Amoroso, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Chemokines; Interleukin 8; Lupus nephritis; Monocyte chemoattractant protein 1; Transforming growth factor

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; CHEMOKINE RECEPTOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

CELLULAR IMMUNITY; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GLOMERULOPATHY; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATION; INFLAMMATORY INFILTRATE; INTERSTITIAL NEPHRITIS; LEUKOCYTE ACTIVATION; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE FUNCTION; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN URINE LEVEL; REVIEW; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; URINALYSIS;

ANIMALS; BIOLOGICAL MARKERS; CHEMOKINES; HUMANS; LUPUS NEPHRITIS; TH1 CELLS; TH2 CELLS;

EID: 34547516067     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. ZLOTNIK A, MORALES J, HEDRICK JA. Recent advances in chemokines and chemokine receptors. Crit Rev Immunol 1999; 19: 1-47.
2. OUACKENBUSH E J, AGUIRRE V, WERSHIL BK, GUTIERREZ RAMOS JC. Eotaxin influences the development of embryonic hematopoietic progenitors in the mouse. J Leukocyte Biol 1997; 62: 661-666.
3. MOORE BB, KEANE MP, ADDISON CL, ARENBERG DA, STRIETER RM. CXC chemokine modulation of angiogenesis: The importance of balance between angiogenic and angiostatic members of the family. J Invest Med 1998; 46: 113-120.
4. BAGGIOLINI M, DEWALD B, MOSER B. Human chemokines: An update. Annu Rev Immunol 1997; 15: 675-705.
5. BAGGIOLINI M, MOSER B. Blocking chemokine receptors. J Exp Med 1997; 186: 1189-1191.
6. ROVIN BH, PHAN LT. Chemotactic factors and renal inflammation. Am J Kidney Dis 1998; 31: 1065-1084.
7. BAGGIOLINI M. Chemokines and leukocyte traffic. Nature 1998; 392: 565-568.
8. SALLUSTO F, LANZAVECCHIA A, MACKAY CR. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 1998; 19: 568-574.
9. COBBOLD S, WALDMANN H. Infectious tolerance. Curr Opin Immunol 1998; 10: 518-524.
10. BONECCHI R, BIANCHI G, BORDIGNON PP, D'AMBROSIO D, LANG R, BORSATTI A, SOZZANI S, ALLAVENA P, GRAY PA, MANTOVANI A, SINIGAGLIA F. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998; 187: 129-134.
11. SALLUSTO F, LENIG D, MACKAY CR, LANZAVECCHIA A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998; 187: 875-883.
12. EMERY P, SALMON M. The immune response. 2. Systemic mediators of inflammation. Br J Hosp Med 1991; 45: 164-168.
13. CROCKETT TORABI E. Selectins and mechanisms of signal transduction. J Leukocyte Biol 1998; 63: 1-14.
14. BOHLE A, WEHRMANN M, BOGENSCHUTZ O, BATZ C, VOGL W, SCHMITT H, MULLER CA, MULLER GA. The long-term prognosis of the primary glomerulonephritides: A morphological and clinical analysis of 1747 cases. Pathol Res Pract 1992; 188: 908-924.
15. SEGERER S, NELSON PJ, SCHLOLDORFF D. Chemokines, chemokine receptors, and renal disease: From basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000; 11: 152-176.
16. SCHLONDORFF D, NELSON PJ, LUCKOW B, BANAS B. Chemokines and renal disease. Kidney Int 1997; 51: 610-621.
17. SATRIANO JA, HORA K, SNAN Z, STANLEY ER, MORI T, SCHLONDORFF D. Regulation of monocyte chemoattractant protein-1 and macrophage colony-stimulating factor-1 by IFN-g, tumor necrosis factor-α, IgG aggregates, and cAMP in recuse mesangial cells. J Immunol 1993; 150: 1971-1978.
18. ROVIN BH, DICKERSON JA, TAN LC, FASSLER J. Modulation of IL-1-induced chemokine expression in human mesangial cells through alterations in redox status. Cytokine 1997; 9: 178-186.
19. LUCKOW B, SCHLONDORFF D, WOLF G. The monocyte chemoattractant protein 1. In: Molecular Nephrology, edited by Schlon̈dorff D, Bonventre JV, New York, Marcel Decker, 1995; 653-671.
20. ROVIN BH, YOSHIUMURA T, TAN L. Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol 1992; 148: 2148-2153.
21. SATRIANO JA, SHULDINER M, HORA K, XING Y, SHAN Z, SCHLONDORFF D. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1. in response to tumor necrosis factor-α and immunoglobulin G: Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J Clin Invest 1993; 92: 1564-1571.
22. PRODJOSUDJADI W, GERRITSMA JS, KLAR MOHAMAD N, GERRITSEN AF, BRULIN JA, DAHA MR, VAN ES LA. Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int 1995; 48: 1477-1486.
23. GERRITSMA JS, VAN KOOTEN C, GERRITSEN AF, MOMMAAS AM, VAN ES LA, DAHA MR. Production of inflammatory mediators and cytokine responsiveness of an SV40-transformed human proximal tubular epithelial cell line. Exp Nephrol 1998; 6: 208-216.
24. DECKERS JG, VAN DER WOUDE FJ, VAN DER KOOU SW, DAHA MR. Synergistic effect of IL-1α, IFN-γ, and TNF-α on RANTES production by human renal tubular epithelial cells in vitro. J Am Soc Nephrol 1998; 9: 194-202.
25. BANAS B, LUCKOW B, MOLLER M, HOLTHOFER H, NELSON PJ, SCHADDE E, BRIGL M, HALEVY D, REINHART B, SCHLONDORFF D. Chemokine and chemokine receptor expression in a novel human mesangial cell line. J Am Soc Nephrol 1999; 10: 2314-2322.
26. SCHWARZ M, RADEKE HH, RESCH K, UCIECHOWSKI P. Lymphocyte derived cytokines induce sequential expression of monocyte- and T cell-specific chemokines in human mesangial cells. Kidney Int 1997; 52: 1521-1531.
27. GOPPELT STRUEBE M, STROEBEL M. Synergistic induction of monocyte chemoattractant protein-1 (MCP-1) by platelet-derived growth factor and interleukin-1. FEBS Lett 1995; 374: 375-378.
28. BECK-SCHIMMER B, OERTLI B, PASCH T, WUTHRICH RP. Hyaluronan induces monocyte chemoattractant protein-1 expression in renal tubular epithelial cells. J Am Soc Nephrol 1998; 9: 2283-2290.
29. DECKERS JG, DE NAU S, VAN DER WOUDE FJ, VAN DER KOOU SW, DAHA MR, VAN KOOTEN C. IL-4 and IL-13 augment cytokine- and CD40-induced RANTES production by human renal tubular epithelial cells in vitro. J Am Soc Nephrol 1998; 9: 1187-1193.
30. WANG Y, RANGAN GK, TAY Y-C, WANG Y, HARRIS DCH. Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor kB in proximal tubule cells. J Am Soc Nephrol 1999; 10: 1204-1213.
31. YOKOYAMA H, WADA T, FURUICHI K, SEGAWA C, SHIMIZU M, KOBAYASHI K, SU S, MUKAIDA N, MATSUSHIMA K. Urinary levels of chemokines (MCAF/MCP-1, IL-8) reflect distinct disease activities and phases of human IgA nephropathy. J Leukocyte Biol 1998; 63: 493-499.
32. PRODJOSUDJADI W, GERRITSMA JS, VAN ES LA, DAHA MR, BRUUN JA. Monocyte chemoattractant protein-1 in normal and diseased human kidneys: An immunohistochemical analysis. Clin Nephrol 1995; 44: 148-155.
33. EITNER F, CUI Y, HUDKINS KL ANDERSON DM, SCHMIDT A, MORTON WR, ALPERS CE. Chemokine receptor (CCR5) expression in human kidneys and in the HIV infected macaque. Kidney Int 1998; 54: 1945-1954.
34. SEGERER S, MACK M, REGELE H, KERIASCHKI D, SCHLONDORFF D. Expression of the C-C chemokine receptor 5 in human kidney diseases. Kidney Int 1999; 56: 52-64.
35. WADA T, FURUICHI K, SEGAWA-TAKAEDA C, SHIMIZU M, SAKAI N, TAKEDA SI, TAKASAWA K, KIDA H, KOBAYASHI KI, MUKAIDA N, OHMOTO Y, MATSUSHIMA K, YOKOYAMA H. MIP-1a and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int 1999; 56: 995-1003.
36. COCKWELL P, BROOKS CJ, ADU D, SAVAGE COS. Interleukin-8. A pathogenetic role in antineutrophil cytoplasmic autoantibody associated glomerulonephritis. Kidney Int 1999; 55: 852-863.
37. BUDDE K, WAISER J, CESKA M, KATALINIC A, KURZDORFER M, NEUMAYER HH. Interleukin-8 expression in patients after renal transplantation. Am J Kidney Dis 1997; 29: 871-880.
38. STREHLAU J, PAVLAKIS M, LIPMAN M, SHAPIRO M, VASCONCELLOS L, HARMON W, STROM TB. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 1997; 94: 695-700.
39. NORIS M, BERNASCONI S, CASIRAGHI F, SOZZANI S, GOTTI E, REMUZZI G, MANTOVANI A. Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab Invest 1995; 73: 804-809.
40. WING-YAN CHAN R, MAC-MOUNE LAI F, KWOK-MING LI E, TAM L, WONG T, et al. Expression of Chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis. Arthritis Rheum 2004; 50: 2282-2890.
41. TAN EM, COHEN AS, FRIES IF, MASI AT, McSHANE DI, ROTHFIELD NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
42. NAOYUKI T, MICHIKO S, AKIHIRO Y, KOJI I. Elevated serum level of soluble HLA class I antigens in patients with systemic lupus erythematosus. Arthritis Rheum 1996; 39: 792-796.
43. BOMBARDIER C, GLADMAN DD, UROWITZ MB, CARON D, CHANG CH, AND THE COMMITEE ON PROGNOSIS STUDIES IN SLE. Derivation of the SLEDAI: A disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-640.
44. NEILSON EG, COUSER WG. Immunologic renal diseases. 2nd ed. Lippincott Willams & Wilkins, 2001.
45. YOSHIOKI K, KATSUMI T, MURAKAMI K, OKADA M, HINO S, MIYANOTO MS. TGFβ-protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 1993; 68: 154-163.
46. BRAD HR, HUUUAN S, DAN JB, LEE AH, CHACK YY, HAIKADY N. Urine chemokines as biomarkers of human systemic lupus erythemathosus activity. J Am Soc Nephrol. 2005; 16: 467-473.
47. KUROIWA T, LEE EG. Cellular interactions in the pathogenesis of lupus nephritis: The role of T cells and macrophages in the amplification of the inflammatory process in the kidney. Lupus 1998; 7: 597-603.
48. PEREZ DE LEMA O, MALER H, NIETO E, VIELHAUER V, LUCKOW B. MAMPASO F. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol 2001; 12: 1369-1382.
49. SEGERER S, NELSON JP, SCHIONDORIF D. Chemokines, chemokine receptors, and renal disease: From basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000; II: 152-176.
50. WADA T, YOKOYAMA H, Su 5, MUKAIDA N, IWANO M, DOHI K, TAKAHASHI Y, SASAKI T, FURUICHI K, SEGAWA C, HISADA Y, OHTA S. Takasawa K, Kobayashi K, Matushima K. Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int 1996; 49: 761-767.
51. YAMATO K, LOSKUTOFF DJ. Expression of transforming growth factor-β and tumor necrosis factor-α in the plasma and tissues of mice with lupus nephritis. Lab Invest 2000; 80: 1561-1570.
52. LI B, HARTONO C, DING R, SHARMA VK, RAMASWAMY R, QIAN B. Non invasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perform and granzyme B in urine. N Engl J Med 2001; 344: 947-954.
53. FOSTER NM, KELLEY VR. Lupus nephritis: Update on pathogenesis and disease mechanisms. Semin Nephrol 1999; 19: 173-181.
54. KELLEY VR, ROVIN BH. Chemokines: Therapeutic targets for autoimmune and inflammatory renal disease. Springer Sem Immunopathol 2003; 24: 411-421.
55. TESCH GH, MAIFERT S. SCHWARTING A, ROLLINS BJ, KELLEY VR. Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-faslpr mice. J Exp Med 1999; 190: 1813-1824.
56. PEREZ DE LEMA G, MAIER H, NIETO E, VIELHAUER V, LUCKOW B, MAMPASO F, SCHLONDORFF D. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol 2001; 12: 1369-1382.
57. TUCCI M, BARNES EV, SOBEL ES, CROKER BP, SEGAL MS, REEVES WH, RICHARDS FIB. Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis. Arthritis Rheum 2004; 50: 1842-1849.
58. WADA T, YOKOYAMA H, TOMOSUGI N, HISADA Y, OHTA S. NAITO T, KOBAYASHI K-I, MUKAIDA N, MATSUSHIMA K. Detection of urinary interleukin-8 in glomerular diseases. Kidney Int 1994; 46: 455-460.
59. TESAR V, MASEK Z, RYCHLIK I, MERTA M, BARTUNKOVA J, STEJSKALOVA A, ZABKA J, JANATKOVA I, FUCIKOVA T, DOSTAL C, BECVAR R. Oytokines and adhesion molecules in renal vasculitis and lupus nephritis. Nephrol Dial Transplant 1998; 13: 1662-1667.
60. TSAI CY, WU TH, YU CL, LU JY, TSAI YY. Increased excretions of132-microglobulin, IL-6, and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in the urine of patients with active lupus nephritis. Nephron 2000; 85: 207-214.